Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The price of weight-loss drugs like Wegovy put them out of reach for most people with obesity, but new arrivals and expiring ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

The FDA said that nearly 142,000 bottles were recalled because of failed dissolution specifications, meaning the medication did not dissolve as it should have, and may not work as effectively, Fox ...

The UK's media regulator has criticised O2 for raising its prices by more than it promised customers when they took out their phone contracts. Ofcom said it was "disappointed" with the firm, and said ...

Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due to "failed dissolution specifications." Several bottle sizes of ...

CINCINNATI (WKRC) - A popular and widely-used medicine was recalled because it may not be as effective as advertised. The Food and Drug Administration announced on October 10 that 141,984 bottles of ...

Camber Pharmaceuticals announced the launch of Eltrombopag, the first and only AB-rated generic equivalent of Promacta®, on May 14, 2025. As the first-to-market AB-rated generic, Eltrombopag offers a ...